Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug;159(8):1562-1568.
doi: 10.1097/j.pain.0000000000001242.

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study

Affiliations

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study

Sachin V Pasricha et al. Pain. 2018 Aug.

Abstract

Concerns over prescription opioids contributing to high levels of opioid use disorder and overdose have led policymakers and clinicians to seek means to reduce inappropriate and high-dose initial prescriptions. To inform such efforts, we sought to describe the clinical indications associated with opioid initiation and the characteristics of the initial prescriptions and patients through a retrospective population-based cohort study. Our cohort included Ontarians initiating prescription opioids for pain management between April 1, 2015, and March 31, 2016. We identified the apparent clinical indication for opioid initiation by linking prescription drug claims to procedural and diagnostic information on health service records on the day of, and 5 days preceding prescription. Outcomes included initial opioid type, prescription duration, and daily dose (in milligram morphine equivalents), stratified either by indication or indication cluster. Among 653,993 individuals, we successfully classified 575,512 (88.0%) people initiating opioids into 23 clinical indications in 6 clusters: dental (23.2%); postsurgical (17.4%); musculoskeletal (12.0%); trauma (11.2%); cancer/palliative care (6.5%); and other less frequent indications (17.7%). Individuals with postsurgical pain received the highest daily doses (40.5% with greater than 50 milligram morphine equivalent), and those with musculoskeletal pain received more initial prescriptions with a duration exceeding 7 days (34.2%). Opioids are initiated for a wide range of indications with varying doses and durations; yet, those who initiated opioids for postsurgical and musculoskeletal pain received the greatest doses and durations of therapy, respectively. These findings may help tailor and prioritize efforts to promote more appropriate opioid prescribing.

PubMed Disclaimer

Conflict of interest statement

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Figures

Figure 1.
Figure 1.
Cohort identification. This figure depicts the order in which inclusion and exclusion criteria were used to identify the study cohort of Ontarians newly initiating opioids between April 1, 2015, and March 31, 2016. ICES, Institute for Clinical Evaluative Sciences.

References

    1. Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR, Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO, Guyatt GH. Guideline for opioid therapy and chronic noncancer pain. CMAJ 2017;189:E659–66. - PMC - PubMed
    1. Canadian Institute for Health Information. The CIHI data quality framework. Ottawa: CIHI, 2009.
    1. Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM. Risk of incident diabetes among patients treated with statins: population based study. BMJ 2013;346:f2610. - PMC - PubMed
    1. Casucci G, Cevoli S. Controversies in migraine treatment: opioids should be avoided. Neurol Sci 2013;34(suppl 1):S125–128. - PubMed
    1. Clarke J. “Difficulty accessing health care services in Canada.” Health at a Glance. Ottawa, ON, Canada: Statistics Canada catalogue no. 82-624-X; 2016.

Substances